We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Microfluidic Device Rapidly Detects Urinary Tract Infections

By LabMedica International staff writers
Posted on 23 Aug 2015
Print article
Image: The workflow of the Lab-on-a-Disc device for identifying bacteria in urine samples. From left to right (i) Urine sample from patient; (ii) Capturing bacteria in V-cup-structures on a Lab-on-a-Disk platform by centrifugation; (iii) Raman spectroscopic analysis of captured bacteria within the V-cups; (iv) Fingerprint-like spectroscopic information on the UTI pathogen (Photo courtesy of Ute Neugebauer).
Image: The workflow of the Lab-on-a-Disc device for identifying bacteria in urine samples. From left to right (i) Urine sample from patient; (ii) Capturing bacteria in V-cup-structures on a Lab-on-a-Disk platform by centrifugation; (iii) Raman spectroscopic analysis of captured bacteria within the V-cups; (iv) Fingerprint-like spectroscopic information on the UTI pathogen (Photo courtesy of Ute Neugebauer).
Image: The alpha300 R Superior Confocal Raman Imaging System (Photo courtesy of WITec).
Image: The alpha300 R Superior Confocal Raman Imaging System (Photo courtesy of WITec).
A polymeric centrifugal microfluidic platform has been developed for the rapid and sensitive identification of bacteria directly from urine, thus eliminating time-consuming cultivation steps.

Untreated urinary tract infections can quickly move to a life-threatening condition and cases may trigger sepsis, which occurs when the immune system, in an attempt to fight off the infection, inadvertently activates body-wide inflammation that can cause blood clots and leaky blood vessels.

Scientists at the Jena University Hospital (Germany) have created a Lab-on-a-Disc platform that combines microfluidics and Raman microscopy, a modern optical detection method. The platform utilizes the rotationally induced centrifugal field to efficiently capture bacteria directly from suspension within a glass-polymer hybrid chip. Once trapped in an array of small V-shaped structures, the bacteria are readily available for spectroscopic characterization, such as Raman spectroscopic fingerprinting, providing valuable information on the characteristics of the captured bacteria.

Anonymized urine samples were provided by the hospital’s Institute of Medical Microbiology. They originated from different patients with single pathogen urinary tract infections (UTIs) of Enterococcus faecalis and Escherichia coli. To remove bigger particles such as leukocytes or epithelial cells, the urine samples were run through membrane filters, centrifuged, the pellet washed twice with phosphate buffered saline (PBS), and is finally re-suspended in PBS before being loaded into the device. A CRM 300 micro-Raman setup (WITec, Ulm, Germany), equipped with a 600 lines/mm grating was used for micro-Raman measurements.

The whole procedure, including sample preparation, requires about one hour to obtain a valuable result, marking a significant reduction in diagnosis time when compared to the 24 hours and more, typically required for standard microbiological methods. Characterization of the captured bacteria by label-free conventional micro-Raman spectroscopy allows rapid identification of the pathogens with their characteristic features, which is valuable for first screening analysis. The device has been easily adapted for fluorescence measurements, paving the way for the development of microfluidics-based immunochemical assays, illustrating a high potential of the device for numerous applications in spectroscopy-based point-of-care diagnostics.

Ulrich-Christian Schröder, a doctoral student and lead author of the study said, “Our device works by loading a few microliters of a patient's urine sample into a tiny chip, which is then rotated with a high angular velocity so that any bacteria is guided by centrifugal force through microfluidic channels to a small chamber where 'V-cup capture units' collect it for optical investigation. We were able to identify Escherichia coli and Enterococcus faecalis within 70 minutes, directly from patients' urine samples.” The study was published on August 11, 2015, in the journal Biomicrofluidics.

Related Links:

Jena University Hospital
WITec 


New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Automated Blood Typing System
IH-500 NEXT
New
Vibrio Cholerae O1/O139 Rapid Test
StrongStep Vibrio Cholerae O1/O139 Antigen Combo Rapid Test
New
Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.